Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mark T Ledwidge"'
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Objective To determine the evidence for non-specific effects of the Pneumococcal and Haemophilus influenza vaccine in children aged 5 years and under.Data sources A key word literature search of MEDLINE, EMBASE, The Cochrane Central Register of Contr
Externí odkaz:
https://doaj.org/article/5ad58482866a4ab0b30bb021afc432ea
Autor:
Dermot M Wildes, Master Chisale, Richard J Drew, Peter Harrington, Chris J Watson, Mark T Ledwidge, Joe Gallagher
Publikováno v:
EClinicalMedicine, Vol 41, Iss , Pp 101164- (2021)
Background: Our goal was to identify existing clinical prediction rules for predicting hospitalisation due to lower respiratory tract infection (LRTI) in children in primary care, guiding antibiotic therapy. A validation of these rules was then perfo
Externí odkaz:
https://doaj.org/article/b08f6c9caaa44243b315feedeb08c254
Autor:
Master Chisale, Chris Watson, Joe Gallagher, Nadezhda Glezeva, Sudipto Das, Richard J Drew, Dermot Michael Wildes, Cillian De Gascun, Tsung-Shu Joseph Wu, Mark T Ledwidge
Publikováno v:
BMJ Open, Vol 11, Iss 7 (2021)
Objective To determine the aetiology of community acquired pneumonia in children presenting to primary care in Northern Malawi, and to ascertain predictors for identification of children requiring hospitalisation.Design The BIOmarkers TO diagnose PnE
Externí odkaz:
https://doaj.org/article/754d878c5945492fa8d28d580c96b7f9
Autor:
Mark T, Ledwidge, Eoin, O'Connell, Joseph, Gallagher, Lesley, Tilson, Stephanie, James, Victor, Voon, Margaret, Bermingham, Elaine, Tallon, Chris, Watson, Rory, O'Hanlon, Michael, Barry, Kenneth, McDonald
Publikováno v:
European journal of heart failure. 17(7)
Prevention of cardiovascular disease and heart failure (HF) in a cost-effective manner is a public health goal. This work aims to assess the cost-effectiveness of the St Vincent's Screening TO Prevent Heart Failure (STOP-HF) intervention.This is a su
Autor:
Linan Xu, Fiachra Humphries, Nezira Delagic, Bingwei Wang, Ashling Holland, Kevin S. Edgar, Jose R. Hombrebueno, Donna Beer Stolz, Ewa Oleszycka, Aoife M. Rodgers, Nadezhda Glezeva, Kenneth McDonald, Chris J. Watson, Mark T. Ledwidge, Rebecca J. Ingram, David J. Grieve, Paul N. Moynagh
Publikováno v:
JCI Insight, Vol 6, Iss 12 (2021)
Evolutionarily conserved signaling intermediate in Toll pathways (ECSIT) is a protein with roles in early development, activation of the transcription factor NF-κB, and production of mitochondrial reactive oxygen species (mROS) that facilitates clea
Externí odkaz:
https://doaj.org/article/0345bb89fc434b80b4c4d1233fd83303